Calprotectin levels in meconium measured with an automated immunoassay (Liaison® XL)

Fiche du document

Date

2023

Type de document
Périmètre
Langue
Identifiant
Collection

Cairn.info

Organisation

Cairn

Licence

Cairn


Sujets proches En

Worth Axiology

Citer ce document

Charlotte Oris et al., « Calprotectin levels in meconium measured with an automated immunoassay (Liaison® XL) », Annales de Biologie Clinique, ID : 10670/1.3d72e2...


Métriques


Partage / Export

Résumé 0

A threshold of 50 μg fecal calprotectin per gram stool sample (μg/g) is commonly used to diagnose chronic inflammatory bowel disease in adult patients and children over 4 years of age. In younger children, fecal calprotectin values are physiologically higher. The objective of our study was to establish, for the first time, reference ranges in newborns for the measurement of meconium calprotectin with an automated assay (Liaison® XL, DiaSorin). A prospective study was conducted in 2022 in the Maternity Unit of the Clermont-Ferrand University Hospital, with the inclusion of full-term newborns without intestinal involvement. The quantitative automated Liaison® XL calprotectin assay was assessed on a panel of meconium samples. In our cohort of 132 term neonates, calprotectin values ranged from 21 to 855 μg/g of meconium (2.5th to 97.5th percentile) and the median value was 194 μg/g. In our cohort, only sex-related differences were observed for calprotectin values. No significant differences were found for the other factors studied (maternal or neonatal). Because of inter-individual variability, a sequential measurement of newborn calprotectin from meconium should be considered.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets